Page 156 - 2017-2018 NSE FACTBOOK.cdr
P. 156

2017/2018 NSE FACT BOOK                                                                                                                                                                                     2017/2018 NSE FACT BOOK
            The Performance Documentary of Listed Nigerian Companies                                                                                                                                    The Performance Documentary of Listed Nigerian Companies






                                                                                                    MAIN BOARD                                                                                                             MAIN BOARD
                    FIDSON HEALTHCARE PLC                                                             HEALTHCARE                                 GLAXOSMITHKLINE CONSUMER NIGERIA PLC                                        HEALTHCARE



            HEAD OFFICE:             CONSOLIDATED STATEMENT OF FINANCIAL POSITION                                                  HEAD OFFICE:             CONSOLIDATED STATEMENT OF FINANCIAL POSITION
            268, Ikorodu Road, Obanikoro, Lagos                                                                                    GSK Nigeria House, 1 Industrial
            ---------------------------------------------------                                                                    Avenue Ilupeju, Lagos
            TELEPHONE:                                               2017     2016      2015     2014     2013                     --------------------------------------------------       2017      2016     2015     2014      2013
            (+234) 01-3421902                                       N'000     N'000    N'000    N'000     N'000                    TELEPHONE:                                              N'000     N'000    N'000     N'000    N'000
            ---------------------------------------------------                                                                    (+234) 1-3425131
            EMAIL:                   Property, plant and equipment   12,363,213   12,206,210   11,501,335   10,790,758   7,043,474   --------------------------------------------------   Property, plant and equipment   2,311,992   2,761,731   13,874,242   13,419,394   12,121,857
            info@fidson.com          Intangibles                     60,184    92,483    11,016.00    22,440    3,245              EMAIL:                    Intangibles                        -         -        -        -         -
            ---------------------------------------------------  Inventories    1,756,629    1,085,535    697,502    1,145,540    1,497,332   uchenna.a.uwechia@gsk.com  Inventories       3,368,426    4,440,834    7,418,238    7,589,550    5,616,340
            WEBSITE:                                                                                                               --------------------------------------------------
            www.fidson.com           Receivables                   2,502,642    2,420,491    3,779,823    3,187,471    2,344,387   WEBSITE:                  Receivables                   7,505,112    5,771,241    6,398,910    5,287,412    4,557,811
            ---------------------------------------------------  Cash and bank balances    359,656    334,228    122,376    204,154    137,027   www.gsk.com.ng  Cash and bank balances    13,309,649    15,215,273    3,638,323    1,696,512    3,917,655
            ISSUED SHARE CAPITAL:    Total Assets                  17,447,718    16,666,935    16,670,325    15,772,494    12,243,088   --------------------------------------------------   Total Assets    26,495,179    28,189,079    31,329,713    27,992,868    26,213,663
            750,000,000                                                                                                            ISSUED SHARE CAPITAL:                                        -
            ---------------------------------------------------                                                                    597,938,244
            DATE  OF INCORPORATION:           Current liabilities    7,088,742    6,642,906    6,646,548    5,909,026    4,070,893   --------------------------------------------------   Current liabilities    9,323,092    11,144,362    16,135,911    13,220,815    11,781,418
            13 March 1995            Non-current liabilities       2,736,056    3,430,763    3,699,949    4,098,187    2,926,860   DATE  OF INCORPORATION:           Non-current liabilities    -       302    2,008,588    1,823,809    2,086,531
            ---------------------------------------------------  Total Liabilities    9,824,798    10,073,669    10,346,497    10,007,213    6,997,753   23 June 1971  Total Liabilities    9,323,092    11,144,664    18,144,499    15,044,624    13,867,949
            DATE  LISTED ON THE EXCHANGE:                                                                                          --------------------------------------------------
            5 June, 2008             Share capital                  750,000    750,000    750,000    750,000    750,000            DATE  LISTED ON THE EXCHANGE:      Share capital         597,939    597,939    597,939    478,351    478,351
            ---------------------------------------------------  Share premium    2,973,043    2,973,043    2,973,043    2,973,043    2,973,043   1977       Share premium                   51,395    51,395    51,395    51,395    51,395
            NSE SECTOR CLASSIFICATION:   Retained earnings         3,899,194    2,871,730    2,602,420    2,043,001    1,521,257   --------------------------------------------------   Retained earnings    16,522,753    16,395,081    12,535,880    12,418,498    11,815,968
            Pharmaceuticals                                                                                                        NSE SECTOR CLASSIFICATION:
            ---------------------------------------------------  Total Equity    7,622,920    6,593,266    6,323,828    5,765,281    5,245,335   Pharmaceuticals  Total Equity            17,172,087    17,044,415    13,185,214    12,948,244    12,345,714
            BOARD OF DIRECTORS:      Total Liabilities and Equity   17,447,718   16,666,935   16,670,325   15,772,494   12,243,088  --------------------------------------------------   Total Liabilities and Equity   26,495,179   28,189,079   31,329,713   27,992,868   26,213,663
            Mr. Felix O. A Ohiwerei                                                                                                BOARD OF DIRECTORS:
            Dr. Fidelis A. Ayebae                                                                                                  Mr. Edmund .C. Onuzo
            Mr. Emmanuel E. Imoagene                                                                                               Mr. Bhushan Akshikar
            Mrs. Olufunmilola O. Ayebae                                                                                            Mr. Samuel Kuye
            Mrs Aishatu. P. Sadauki                                                                                                Mr. Tunde Lemo OFR
            Ms. Mabel Ndagi          CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME                                                Mrs. Lubabatu Bello      CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
            Mr. Olusegun S. Adebanji                                                                                               Mr. Kareem Hamdy
            Mr. Olugbenga O. Olayeye                                                                                               --------------------------------------------------
            Mr. Abiola A. Adebayo                                                                                                  COMPANY SECRETARY:
            ---------------------------------------------------      2017     2016      2015     2014     2013                     Uchenna Uwechia                                          2017      2016     2015     2014      2013
            COMPANY SECRETARY:                                      N'000     N'000    N'000    N'000     N'000                    Address: GSK House, 1 Industrial                        N'000     N'000    N'000     N'000    N'000
            Mr. J. Abayomi Adebanjo FCIS  Revenue                 14,057,394  7,655,029  8,210,000  9,719,185  9,235,056           Avenue Ilupeju, Lagos     Revenue                     16,089,728  14,384,785  15,391,585  30,521,127  29,183,675
            Address: 268, Ikorodu Road Obanikoro,   Profit before tax  1,578,547  443,787  838,039  870,812  249,591               Email: uchenna.a.uwechia@gsk.com  Profit before tax    1,124,269  185,891  1,065,601  2,752,216  4,314,829
            Lagos                                                                                                                  Telephone: (+234)7055200282
            Email: yomiadebanjo@fidson.com  Taxation                517,758    127,025    93,661    238,987    94,611              --------------------------------------------------   Taxation (expense)/credit   (637,836)   2,192,254    (192,467)   (903,374)   (1,395,659)
            Telephone: +234 08023146760 ,   Profit after tax       1,060,789  316,762  744,378  631,825  154,980                   AUDITORS                  Profit after tax              486,433  2,378,145  873,134  1,848,842  2,919,170
            08098140571              Transfer to revenue reserve    760,789  241,762   669,378  406,825    4,980                   Deloitte                  Transfer to revenue reserve   486,433  2,378,145  873,134  1,848,842  2,919,170
            ---------------------------------------------------                                                                    Address: Civic Centre Towers Plot GA
            AUDITORS                                                                                                               1, Ozumba Mbadiwe Avenue Victoria
            Ernst & Young (outgoing)  Profit attributable to:                                                                      Island Lagos              Profit attributable to:
            Address: 13th Floor UBA House,                                                                                         Email: audenani@deloitte.com
                                     owners of the Company         1,060,789  316,762  744,378  631,825  154,980                                             owners of the Company         486,433  2,378,145  873,134  1,848,842  2,919,170
            Marina, Lagos Island.                                                                                                  Telephone: (+234)1-2717800
            Email: services@ng.ey.com  Non-controlling interest                                                                    --------------------------------------------------   Non-controlling interest   -      -      -      -      -
            Telephone: +234 01- 4630479-80  ,                                                                                      COMPANY REGISTRARS:
            4630481                  Earnings per 50k share [k]       71k       21k      50k       42k      10k                    GTL Registrars Limited    Earnings per 50k share [k]       41        199       96       193      305
            ---------------------------------------------------  Net assets per 50k share [k]   508   440   422   384   350        Address:274, Murtala Muhammed   Net assets per 50k share [k]   14.36   14.25   11.03   27.06    25.81
            COMPANY REGISTRARS:                                                                                                    Way Yaba Lagos
            Meristem Registrars                                                                                                    Email: tcmadubueze@gtlregistrars
            Address: 213 Herbert Macaulay Way,                                                                                     .com
            Adekunle Yaba.lagos                                                                                                    Telephone: (+234)1-2917747
            Email: info@meristemregistrars.com                                                                                     --------------------------------------------------
            Telephone: (+234) 01-8920491                                                                                           CAPITAL STRUCTURE:
            ---------------------------------------------------                                                                    Authorized: 1,500,000,000 Ordinary
            CAPITAL STRUCTURE:                                                                                                     Shares
            Authorized:  N1,200,000,000                                                                                            Paid Up: 1, 195,876,488 Ordinary
            Paid Up: 750,000,000                                                                                                   Shares










    2017/2018 NSE FACTBOOK                                                                                                                                                                                                                   2017/2018 NSE FACTBOOK








  154                                                                                                                                                                                                                                      155
   151   152   153   154   155   156   157   158   159   160   161